Comparison of Oncotype Dx (ODx) 21-gene recurrence score (RS) in African American (AA) and Caucasian (C) patients with hormone receptor-positive (HR+), HER2-negative (HER2-), lymph node-negative (LNN) breast cancer (BC)

被引：0
|
作者：
Kabaker, K. B.
Canar, J.
Rao, R. D.
Cobleigh, M. A.
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[2] Edward Hines Jr VA Hosp, Hines, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.620
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
620
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer
    Rakha, Emad A.
    Agarwal, Devika
    Green, Andrew R.
    Ashankyty, Ibraheem
    Ellis, Ian O.
    Ball, Graham
    Alaskandarany, Mohammed A.
    HISTOPATHOLOGY, 2017, 70 (04) : 622 - 631
  • [22] Distribution patterns of 21-gene recurrence score in 980 Chinese estrogen receptor-positive, HER2-negative early breast cancer patients
    Wu Jiayi
    Fang Yan
    Lin Lin
    Fei Xiaochun
    Gao Weiqi
    Zhu Siji
    Zong Yu
    Chen Xiaosong
    Huang Ou
    He Jianrong
    Zhu Li
    Chen Weiguo
    Li Yafen
    Shen Kunwei
    ONCOTARGET, 2017, 8 (24) : 38706 - 38716
  • [23] Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer
    Seitz, K.
    Goossens, C.
    Huebner, H.
    Gass, P.
    Uhrig, S.
    Heindl, F.
    Emons, J.
    Ruebner, M.
    Anetsberger, D.
    Hartmann, A.
    Beckmann, M. W.
    Erber, R.
    Hack, C. C.
    Fasching, P. A.
    Haeberle, L.
    ESMO OPEN, 2024, 9 (11)
  • [24] Complementing Ipsilateral Breast Tumor Recurrence (IBTR!) Estimates With the 21-Gene Recurrence Score (RS) in Early-Stage, Hormone Receptor-Positive, HER2-Normal, Lymph Node-Negative Breast Cancers
    Thaker, N.
    Hoffman, K. E.
    Pusztai, L.
    Buchholz, T. A.
    Woodward, W. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S100 - S101
  • [25] APOBEC signature, clinical characteristics, and outcome in hormone receptor-positive (HR+) HER2-negative (HER2-) breast cancer (BC) patients (pts) in real-world data (RWD)
    Chumsri, Saranya
    Raskina, Kira
    Sammons, Sarah
    Alder, Laura
    Danziger, Natalie
    Schrock, Alexa B.
    McGregor, Kim
    Sokol, Ethan
    CANCER RESEARCH, 2022, 82 (04)
  • [26] Clinical significance of 21-gene recurrence score assay for hormone receptor-positive, lymph node-negative breast cancer in early stage
    Yang Yu-qing
    Wang Lei
    Huang Mei-ling
    Xiao Jing-jing
    Wei Mei-chen
    Wu Jiang
    Hao Jun-sheng
    Ling Rui
    Li Nan-lin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 108 : 150 - 155
  • [27] Comparison of 21-gene recurrence score (RS) in African-American (AA) and Caucasian (C) patients with hormone receptor (HR)-positive early-stage breast cancer.
    Davis, K. M.
    Zelnak, A. B.
    Murali, S.
    Senior-Crosby, D.
    Gabram-Mendola, S.
    Carlson, G. W.
    Wood, W. C.
    Wang, C.
    Styblo, T. M.
    O'Regan, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Comparison of the prognostic performance between OncoMasTR and OncotypeDX multigene signatures in hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
    Kelly, Catherine Margaret
    Crown, John
    Russell, Niamh
    Barron, Stephen
    Lynch, Seodhna
    O'Grady, Anthony
    Sheehan, Katherine
    Fay, Joanna
    Amberger-Murphy, Verena
    Saha, Anurati
    Loughman, Tony
    Dynoodt, Peter
    Fender, Bozena
    Ruiz, Cesar Lopez
    Wang, Chan-Ju Angel
    O'Leary, Desmond
    O'Connor, Darran
    Gallagher, William M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [29] Surgical Management of the Axilla in Patients Presenting with Clinically Node Positive Hormone Receptor Positive, HER2 Negative (HR+/HER2-) Breast Cancer
    Jasper, Jacob
    Kantor, Olga
    Dorninici, Laura
    Nakhlis, Faina
    Ogayo, Esther
    Nimbkar, Suniti
    Kurt, Busem Binbogct
    King, Tari
    Mittendorf, Elizabeth
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S101 - S101
  • [30] BCT score predicts chemotherapy benefit in Asian patients with hormone receptor- positive, HER2-negative, lymph node-negative breast cancer
    Kwon, Mi Jeong
    Lee, Sae Byul
    Han, Jinil
    Lee, Jeong Eon
    Lee, Jong Won
    Gong, Gyungyub
    Beitsch, Peter D.
    Nem, Seok Jin
    Ahn, Sei Hyun
    Nam, Byung-Ho
    Shin, Young Kee
    PLOS ONE, 2018, 13 (11):
12345